Vpa Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
- Paid Up Capital ₹ 0.60 M
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.10 M
- Revenue Growth -21.20%
- Profit Growth -44.37%
- Ebitda -46.41%
- Net Worth 3.33%
- Total Assets -1.52%
About Vpa Pharmaceutical
Vpa Pharmaceutical Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 August 2017 (Seven years and five months 23 days old ). Its registered office is in Sonipat, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹2.10 M.
Vinod Khatri and Abhishek Khatri serve as directors at the Company.
Company Details
-
Location
Sonipat, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74995HR2017PTC070386
-
Company No.
070386
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Aug 2017
-
Date of AGM
30 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Vpa Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Khatri
|
Director | 17-Aug-2017 | Current |
|
Abhishek Khatri
|
Director | 10-Jul-2018 | Current |
Financial Performance of Vpa Pharmaceutical.
Vpa Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.2% decrease. The company also saw a substantial fall in profitability, with a 44.37% decrease in profit. The company's net worth moved up by a moderate rise of 3.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vpa Pharmaceutical?
Unlock access to Vpa Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹2.10 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.21 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Sep 2022 | Canara Bank | ₹2.10 M | Open |
How Many Employees Work at Vpa Pharmaceutical?
Unlock and access historical data on people associated with Vpa Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vpa Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vpa Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
